-
1
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women
-
Writing Group for the Women's Health Initiative investigators.
-
Writing Group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;228:321-33
-
(2002)
JAMA
, vol.228
, pp. 321-333
-
-
-
2
-
-
0035143147
-
Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: Histomorphometric evidence in a longitudinal study
-
DOI 10.1210/jc.86.1.289
-
Khastgir G, Studd JWW, Holland N, et al. Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: histomorphometric evidence in a longitudinal study. J Clin Endocrinol Metab 2001;86: 289-95 (Pubitemid 32109808)
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.1
, pp. 289-295
-
-
Khastgir, G.1
Studd, J.2
Holland, N.3
Alaghband-Zadeh, J.4
Fox, S.5
Chow, J.6
-
3
-
-
0034953814
-
Anabolic effect of long-term estrogen replacement on bone collagen in elderly postmenopausal women with osteoporosis
-
DOI 10.1007/s001980170091
-
Khastgir G, Studd J, Holland N, et al. Anabolic effect of long-term estrogen replacement on bone collagen in elderly postmenopausal women with osteoporosis. Osteoporosis Int 2001;12:465-70 (Pubitemid 32607089)
-
(2001)
Osteoporosis International
, vol.12
, Issue.6
, pp. 465-470
-
-
Khastgir, G.1
Studd, J.2
Holland, N.3
Alaghband-Zadeh, J.4
Sims, T.J.5
Bailey, A.J.6
-
4
-
-
34547180996
-
Low intervertebral disc height in postmenopausal women with osteoporotic vertebral fractures compared to hormone-treated and untreated postmenopausal women and premenopausal women without fractures
-
DOI 10.1080/13697130701460640, PII 780572718
-
Muscat Baron Y, Brincat MP, Galea R, Callega N. Low intervertebral disc height in postmenopausal women with osteoporotic vertebral fractures compared to hormone-treated and untreated postmenopausal women and premenopausal women without fractures. Climacteric 2007;10:314-19 (Pubitemid 47123947)
-
(2007)
Climacteric
, vol.10
, Issue.4
, pp. 314-319
-
-
Baron, Y.M.1
Brincat, M.P.2
Galea, R.3
Calleja, N.4
-
5
-
-
0042093742
-
Estrogen plus progestin and the risk of coronary heart disease
-
DOI 10.1056/NEJMoa030808
-
Manson JE, Hsia J, Johnson KC, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349:523-34 (Pubitemid 36951364)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.6
, pp. 523-534
-
-
Manson, J.A.E.1
Hsia, J.2
Johnson, K.C.3
Rossouw, J.E.4
Assaf, A.R.5
Lasser, N.L.6
Trevisan, M.7
Black, H.R.8
Heckbert, S.R.9
Detrano, R.10
Strickland, O.L.11
Wong, N.D.12
Crouse, J.R.13
Stein, E.14
Cushman, M.15
-
6
-
-
1842867053
-
Effects of Conjugated Equine Estrogen in Postmenopausal Women with Hysterectomy: The Women's Health Initiative Randomized Controlled Trial
-
DOI 10.1001/jama.291.14.1701
-
Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trail. JAMA 2004;291:1701-12 (Pubitemid 38489892)
-
(2004)
Journal of the American Medical Association
, vol.291
, Issue.14
, pp. 1701-1712
-
-
Anderson, G.L.1
Limacher, M.2
-
7
-
-
68949088507
-
Estrogens as first-choice therapy for osteoporosis prevention and treatment in women under 60
-
Studd JWW. Estrogens as first-choice therapy for osteoporosis prevention and treatment in women under 60. Climacteric 2009;12:206-9
-
(2009)
Climacteric
, vol.12
, pp. 206-209
-
-
Studd, J.W.W.1
-
8
-
-
43049129258
-
Low-energy femoral shaft fractures associated with alendronate use
-
DOI 10.1097/BOT.0b013e318172841c, PII 0000513120080500000011
-
Neviaser AS, Lane JM, Lenart BA, et al. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 2008;22:346-50 (Pubitemid 351630250)
-
(2008)
Journal of Orthopaedic Trauma
, vol.22
, Issue.5
, pp. 346-350
-
-
Neviaser, A.S.1
Lane, J.M.2
Lenart, B.A.3
Edobor-Osula, F.4
Lorich, D.G.5
-
9
-
-
77956542068
-
Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: Case-control analysis within a UK primary care cohort
-
Green J, Czanner G, Reeves G, Watson J, Wise L, Beral V. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. BMJ 2010;341:c4444
-
(2010)
BMJ
, vol.341
-
-
Green, J.1
Czanner, G.2
Reeves, G.3
Watson, J.4
Wise, L.5
Beral, V.6
-
10
-
-
49749141653
-
Use of proton pump inhibitors and risk of osteoporosis-related fractures
-
Targownik LE, Lix LM, Metge CJ, et al. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ 2008;179:319-26
-
(2008)
CMAJ
, vol.179
, pp. 319-326
-
-
Targownik, L.E.1
Lix, L.M.2
Metge, C.J.3
-
11
-
-
1642367713
-
Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: The PERF study
-
DOI 10.1016/j.bone.2003.12.021, PII S8756328203004794
-
Bagger YZ, Tanko LB, Alexandersen P, et al. Two to three years of hormone replacement treatment in healthy women has long term preventative effects on bone mass and osteoporotic fracture: the PERF study. Bone 2004;34:728-35 (Pubitemid 38393810)
-
(2004)
Bone
, vol.34
, Issue.4
, pp. 728-735
-
-
Bagger, Y.Z.1
Tanko, L.B.2
Alexandersen, P.3
Hansen, H.B.4
Mollgaard, A.5
Ravn, P.6
Qvist, P.7
Kanis, J.A.8
Christiansen, C.9
-
12
-
-
0035013748
-
Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: A double-blind, randomized, placebo-controlled trial
-
Soares CN, Almeida, Joff H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58:529-34 (Pubitemid 32523731)
-
(2001)
Archives of General Psychiatry
, vol.58
, Issue.6
, pp. 529-534
-
-
De Novaes Soares, C.1
Almeida, O.P.2
Joffe, H.3
Cohen, L.S.4
-
13
-
-
0029880327
-
Transdermal oestrogen for treatment of severe postnatal depression
-
DOI 10.1016/S0140-6736(96)91414-2
-
Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal estrogen for the treatment of severe post-natal depression. Lancet 1996;347:930-3 (Pubitemid 26102548)
-
(1996)
Lancet
, vol.347
, Issue.9006
, pp. 930-933
-
-
Gregoire, A.J.P.1
Kumar, R.2
Everitt, B.3
Henderson, A.F.4
Studd, J.W.W.5
-
14
-
-
0024433568
-
Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone
-
Watson NR, Studd JW, Savvas M, Garnett T, Baber RJ. Treatment of severe premenstrual syndrome with estradiol patches and cyclical oral norethisterone. Lancet 1989;2:730-2 (Pubitemid 19243126)
-
(1989)
Lancet
, vol.2
, Issue.8665
, pp. 730-732
-
-
Watson, N.R.1
Savvas, M.2
Baber, R.J.3
Studd, J.W.4
Garnett, T.5
-
15
-
-
10944221234
-
Hormones and depression in women
-
DOI 10.1080/13697130400012262
-
Studd J, Panay N. Hormones and depression in women. Climacteric 2004;7:338-46 (Pubitemid 40018327)
-
(2004)
Climacteric
, vol.7
, Issue.4
, pp. 338-346
-
-
Studd, J.1
Panay, N.2
-
16
-
-
38649109856
-
Increase in antidepressant medication in the US adult population between 1990 and 2003
-
DOI 10.1159/000112885
-
Mojtabai R. Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychother Psychosom 2008;77:83-92 (Pubitemid 351172098)
-
(2008)
Psychotherapy and Psychosomatics
, vol.77
, Issue.2
, pp. 83-92
-
-
Mojtabai, R.1
-
17
-
-
73149121141
-
Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study
-
Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med 2009;169:2128-39
-
(2009)
Arch Intern Med
, vol.169
, pp. 2128-2139
-
-
Smoller, J.W.1
Allison, M.2
Cochrane, B.B.3
-
18
-
-
33947586737
-
Why are estrogens rarely used for the treatment of depression in women?
-
Studd JW. Why are estrogens rarely used for the treatment of depression in women? Gynecol Endocrinol 2007;23:63-4
-
(2007)
Gynecol Endocrinol
, vol.23
, pp. 63-64
-
-
Studd, J.W.1
-
19
-
-
70350520229
-
Use of antidepressants for management of hot flushes
-
Carroll DG, Kelley KW. Use of antidepressants for management of hot flushes. Pharmacotherapy 2009;29:1357-74
-
(2009)
Pharmacotherapy
, vol.29
, pp. 1357-1374
-
-
Carroll, D.G.1
Kelley, K.W.2
|